Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Danaher Corp
(NY:
DHR
)
200.39
-4.61 (-2.25%)
Official Closing Price
Updated: 6:30 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Danaher Corp
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch
March 28, 2025
Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.
Via
StockStory
Topics
Economy
Exposures
Supply Chain
Looking Into Danaher's Recent Short Interest
March 25, 2025
Via
Benzinga
Movers and shakers in today's after-hours session for S&P500 stocks?
March 24, 2025
The US market session of Monday is over, let's have a look at the top S&P500 gainers and losers in the after hours session today.
Via
Chartmill
Behind the Scenes of Danaher's Latest Options Trends
March 24, 2025
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
February 26, 2025
Via
Benzinga
Danaher's Options Frenzy: What You Need to Know
February 21, 2025
Via
Benzinga
P/E Ratio Insights for Danaher
February 20, 2025
Via
Benzinga
Danaher's Options Frenzy: What You Need to Know
February 12, 2025
Via
Benzinga
Check Out What Whales Are Doing With DHR
March 21, 2025
Via
Benzinga
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)
March 20, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Waters Corporation (NYSE:WAT) and its peers.
Via
StockStory
Topics
Economy
Exposures
Supply Chain
Unpacking the Latest Options Trading Trends in Danaher
March 14, 2025
Via
Benzinga
Forecasting The Future: 10 Analyst Projections For Danaher
March 14, 2025
Via
Benzinga
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR)
March 12, 2025
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bruker (NASDAQ:BRKR) and its peers.
Via
StockStory
Topics
Economy
Exposures
Supply Chain
Danaher Unusual Options Activity For February 07
February 07, 2025
Via
Benzinga
Danaher's Options: A Look at What the Big Money is Thinking
February 03, 2025
Via
Benzinga
Danaher (DHR): Buy, Sell, or Hold Post Q4 Earnings?
March 11, 2025
Shareholders of Danaher would probably like to forget the past six months even happened. The stock dropped 23.9% and now trades at $207. This might have investors contemplating their next move.
Via
StockStory
Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
March 05, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers.
Via
StockStory
Topics
Economy
Exposures
Supply Chain
Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks
March 04, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst...
Via
StockStory
Topics
Economy
Exposures
Supply Chain
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor
February 25, 2025
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.
Via
Benzinga
3 Stocks Offering Strong Value and Stability
February 24, 2025
These stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance.
Via
MarketBeat
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
February 20, 2025
Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 18, 2025
Via
Benzinga
Super Investors Just Bought These Stocks
February 18, 2025
Every quarter, we get to see what the best of the best have bought and sold.
Via
The Motley Fool
3 Healthcare Stocks Skating on Thin Ice
February 12, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and...
Via
StockStory
Topics
Stocks
Exposures
COVID-19
US Equities
Waters Corporation Earnings: What To Look For From WAT
February 11, 2025
Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow before the bell. Here’s what to look for.
Via
StockStory
Jim Cramer Likes This Utilities Stock: 'I Think You've Got A Good One'
February 07, 2025
NextEra Energy posted in-line earnings for the fourth quarter and said it continues to expect adjusted EPS of $3.45-$3.70 for fiscal 2025.
Via
Benzinga
Avantor Earnings: What To Look For From AVTR
February 06, 2025
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know.
Via
StockStory
Earnings To Watch: Mettler-Toledo (MTD) Reports Q4 Results Tomorrow
February 05, 2025
Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via
StockStory
This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
February 03, 2025
Via
Benzinga
Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates
January 31, 2025
Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per...
Via
StockStory
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.